CD8A and melanoma: Specifically, we subjected a series of established and patient-derived xenograft (PDX)-derived melanoma cell lines27, which all endogenously express HLA-A*02:01 and MART-1, in vitro to healthy donor CD8 T cells that had been retrovirally transduced with a T cell receptor recognizing MART-128.